loader
Please Wait
Applying Filters...
menu
    • menu

    Technical details about LNS8801, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    LNS8801

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Gpr30 agonist, g-1, G-1, 881639-98-1, Lns8801, Lns-8801, Tfs4qe36zg
    Molecular Formula
    C21H18BrNO3
    Molecular Weight
    412.3  g/mol
    InChI Key
    VHSVKVWHYFBIFJ-HKZYLEAXSA-N
    FDA UNII
    TFS4QE36ZG
    G Protein-coupled Estrogen Receptor Agonist LNS8801 is an orally bioavailable selective agonist of the G protein-coupled estrogen receptor (G protein-coupled estrogen receptor 1; GPER; GPER1; GPR30), with potential immunomodulating and antineoplastic activities. Upon oral administration, LNS8801 targets, binds to and activates GPER. This activates GPER-mediated signaling and suppresses the expression of various tumor-associated genes, such as c-Myc and programmed cell death-ligand 1 (PD-L1). This leads to an inhibition of tumor cell proliferation. GPER activation may also induce immune memory. GPER is a membrane protein and a member of the G-protein coupled receptors (GPCRs) that are widely distributed in various tissues. GPER is a tumor suppressor in a wide range of cell cancer types.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[(3aS,4R,9bR)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethanone
    2.1.2 InChI
    InChI=1S/C21H18BrNO3/c1-11(24)12-5-6-18-15(7-12)13-3-2-4-14(13)21(23-18)16-8-19-20(9-17(16)22)26-10-25-19/h2-3,5-9,13-14,21,23H,4,10H2,1H3/t13-,14+,21-/m1/s1
    2.1.3 InChI Key
    VHSVKVWHYFBIFJ-HKZYLEAXSA-N
    2.1.4 Canonical SMILES
    CC(=O)C1=CC2=C(C=C1)NC(C3C2C=CC3)C4=CC5=C(C=C4Br)OCO5
    2.1.5 Isomeric SMILES
    CC(=O)C1=CC2=C(C=C1)N[C@H]([C@@H]3[C@H]2C=CC3)C4=CC5=C(C=C4Br)OCO5
    2.2 Other Identifiers
    2.2.1 UNII
    TFS4QE36ZG
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone

    2. G-1 Cpd

    2.3.2 Depositor-Supplied Synonyms

    1. Gpr30 Agonist, G-1

    2. G-1

    3. 881639-98-1

    4. Lns8801

    5. Lns-8801

    6. Tfs4qe36zg

    7. Y3v5bv7okm

    8. G 1 (anti-tumor Agent)

    9. Chembl569766

    10. 1-[(3as,4r,9br)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta[c]quinolin-8-yl]ethanone

    11. G1

    12. 925419-53-0

    13. Ethanone, 1-((3as,4r,9br)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)-

    14. G-1 Cpd

    15. Sr-01000506928

    16. Gper Agonist

    17. Unii-tfs4qe36zg

    18. Unii-y3v5bv7okm

    19. G 1 (gper Agonist)

    20. Gtpl1014

    21. Schembl12700948

    22. Cid_3136849

    23. Cid_5322399

    24. Chebi:156296

    25. Hms3414a07

    26. Hms3650i22

    27. Hms3678a07

    28. Ml051

    29. Ex-a3642

    30. Zinc4172149

    31. Bdbm50303803

    32. Stk330808

    33. Akos015969580

    34. 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone

    35. Hy-107216

    36. Cs-0027669

    37. Unm000000675701

    38. Unm000011063001

    39. Sr-01000506928-1

    40. Sr-01000506928-3

    41. Q27077759

    42. G 1 (g Protein-coupled Estrogen Receptor Agonist)

    43. (+/-)-1-[(3ar*,4s*,9bs*)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta[c]quinolin-8-yl]- Ethanone

    44. 1-((3as,4r,9br)-4-(6-bromobenzo[d][1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta[c]quinolin-8-yl)ethanone

    45. 1-[4-(6-bromo-benzo[1,3]dioxol-5-yl)-3-alpha-4,5,9-beta-tetrahydro-3h-cyclopenta[c]quinolin-8-yl]-ethanone

    46. Ethanone, 1-((3ar,4s,9bs)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)-, Rel-

    2.4 Create Date
    2006-01-19
    3 Chemical and Physical Properties
    Molecular Weight 412.3 g/mol
    Molecular Formula C21H18BrNO3
    XLogP34.6
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count2
    Exact Mass411.04701 g/mol
    Monoisotopic Mass411.04701 g/mol
    Topological Polar Surface Area47.6 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity596
    Isotope Atom Count0
    Defined Atom Stereocenter Count3
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1